COVERAGE OF ORAL ANTI-NAUSEA DRUGS UNDER CHEMOTHERAPEUTIC REGIMEN.

SEC. 4557. COVERAGE OF ORAL ANTI-NAUSEA DRUGS UNDER CHEMOTHERAPEUTIC REGIMEN. (a) In General.—Section 1861(s)(2) (42 U.S.C. 1395x(s)(2)), as amended by sections 4104 and 4105, is amended— (1) by striking “and” at the end of subparagraph (R); and (2) by inserting after subparagraph (S) the following new subparagraph: “(T) an oral drug (which is approved by the Federal Food and Drug Administration) prescribed for use as an acute antiemetic used as part of an anticancer chemotherapeutic regimen if the drug is administered by a physician (or as prescribed by a physician)— “(i) for use immediately before, at, or within 48 hours after the time of the administration of the anticancer chemotherapeutic agent; and “(ii) as a full replacement for the anti-emetic therapy which would otherwise be administered intravenously.”. (b) Effective Date.—The amendments made by subsection (a) shall apply to items and services furnished on or after January 1, 1998.